08
Sep

Ophthotech says it won a $50 million enrollment milestone from Novartis for reaching a goal on its Phase III Fovista study for wet, age-related macular degeneration. …read more

Source: Ophthotech wins a $50M milestone from Novartis

    

0 No comments